Healthcare Industry News 2 December 2025

GSK Stock (LON:GSK, NYSE:GSK): Latest News, FDA Catalysts and 2026 Outlook – December 11, 2025

GSK plc stock has quietly morphed from a problem child of Big Pharma into one of 2025’s more interesting “value with growth” stories. The shares are trading near multi‑year highs, the company has upgraded guidance, big litigation overhangs are easing,

11 December 2025

FDA Updates·Healthcare Industry·Investment Outlook·Market News

UnitedHealth Group (UNH) Stock Forecast 2026: Can the Healthcare Giant Recover From 2025’s Crises?

Published: December 10, 2025 – All data current as of market close on this date. This article is for informational purposes only and is not investment advice. UnitedHealth Group stock today: A blue chip in the penalty box UnitedHealth Group

10 December 2025

Financial Forecasts·Healthcare Industry·Investment Analysis·Stock Market

Merck Stock (MRK) Today – Keytruda Developments, Analyst Price Targets and 2025–2026 Forecast

Merck & Co., Inc. (NYSE: MRK) is back in the spotlight as Wall Street raises price targets, new clinical data hit the tape, and a wave of product approvals and partnerships reshapes the outlook for its blockbuster cancer franchise Keytruda

10 December 2025

Financial Forecasts·Healthcare Industry·Investment Analysis·Pharmaceuticals·Stock Market

Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Updated December 7, 2025 – for information only, not investment advice. Novo Nordisk stock today: from market darling to turnaround story Novo Nordisk (NYSE: NVO), the Danish giant behind GLP‑1 blockbusters Wegovy and Ozempic, has gone from Europe’s most valuable

7 December 2025

Financial News·Healthcare Industry·Investment Analysis·Pharmaceuticals·Stock Market

Medtronic (MDT) Stock News Today: Hugo Robot FDA Clearance, Diabetes Spin-Off and Dividend Strength Shape 2026 Outlook

As of the close on 5 December 2025, Medtronic plc (NYSE: MDT) stock trades around $101.36–$101.39 per share, giving the medical device giant a market capitalization of roughly $130 billion, a P/E ratio near 27.4, and a dividend yield of

6 December 2025

Company Analysis·Dividend Investing·Healthcare Industry·Medical Technology·Stock Market News

UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth Group Incorporated (NYSE: UNH) is back in focus after a bruising year that saw the stock plunge to a five‑year low, attract a U.S. Department of Justice investigation, suffer the largest healthcare data breach in U.S. history – and

5 December 2025

Financial Forecasts·Healthcare Industry·Investment Strategies·Legal Risks·Stock Market

CSL Limited (ASX:CSL) Share Price on 4 December 2025: Restructuring Fallout, New Vaccine Plant and 2026 Stock Forecast

Updated: 4 December 2025 CSL Limited (ASX:CSL), the Australian biotech heavyweight, is trading around A$183 per share on 4 December 2025 after one of the most bruising years in its modern history. The company has delivered solid profit growth, announced

4 December 2025

ASX Updates·Company Analysis·Healthcare Industry·Investment Forecasts

McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson Corporation (NYSE: MCK) is ending 2025 as one of the standout performers in U.S. healthcare — but as of Wednesday, December 3, its stock is taking a breather. At the close, McKesson shares finished at $805.37, down 2.93% on

4 December 2025

Financial Outlook·Healthcare Industry·Investment Analysis·Stock Market

HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare, Inc. (NYSE:HCA) is ending 2025 on a powerful note. After a year of double‑digit earnings growth and upgraded guidance, HCA stock is trading just above $500 per share, close to its 52‑week high of $520 and implying a

3 December 2025

Earnings Reports·Healthcare Industry·Investment Analysis·Stock Market

Johnson & Johnson (JNJ) Stock Near Record Highs: New EU Drug Approval, Oncology Deal and 2026 Outlook

As of December 2, 2025, Johnson & Johnson (NYSE: JNJ) is trading just below all‑time highs, supported by a powerful 2025 rally, a fresh European Union drug approval, a new $3.05 billion oncology acquisition, and a planned spin‑off of its

2 December 2025

Business News·Healthcare Industry·Investing·Pharmaceuticals·Stock Market

CSL Limited (ASX:CSL) Stock Outlook on 2 December 2025: Share Price Slump, Seqirus Spin-Off, New Vaccine Plant and a A$750m Buyback

Updated: 2 December 2025 CSL Limited’s share price has spent most of 2025 in the sin bin, but behind the drawdown sits a mix of solid earnings growth, a radical restructuring, a forthcoming spin‑off of its vaccines arm and fresh

2 December 2025

Corporate News·Healthcare Industry·Investment Analysis·Stock Market

CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

Data and news current as of December 1, 2025. This article is for informational purposes only and is not financial advice. CVS Health Stock Today: A Big 2025 Comeback, Slightly Off the Highs CVS Health Corporation (NYSE: CVS) has staged

2 December 2025

Dividend Stocks·Financial Forecasts·Healthcare Industry·Investing·Stock Market

Healthcare Industry News 2 December 2025 - 11 December 2025